$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Long-term effects of postnatal amphetamine treatment on striatal protein kinase A activity, dopamine D1-like and D2-like binding sites, and dopamine content

Neurotoxicology and teratology, v.22 no.6, 2000년, pp.799 - 804  

Crawford, Cynthia A (Corresponding author. Tel.: +1-909-880-7416) ,  Zavala, Arturo R (fax: +1-909-880-7003) ,  Karper, Patrick E (Department of Psychology, California State University, 5500 University Parkway, San Bernardino, CA 92407-2397, USA) ,  McDougall, Sanders A (Department of Psychology, California State University, 5500 University Parkway, San Bernardino, CA 92407-2397, USA)

Abstract AI-Helper 아이콘AI-Helper

AbstractThe purpose of the present study was to determine whether exposure to amphetamine during the preweanling period would alter dopaminergic functioning in the dorsal striatum of adult rats. In three experiments, we assessed the effects of repeated amphetamine treatment on striatal protein kinas...

주제어

참고문헌 (40)

  1. J. Pharmacol. Exp. Ther. Barnett 242 40 1987 Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization 

  2. Neurosci. Biobehav. Rev. Beninger 22 335 1998 10.1016/S0149-7634(97)00019-5 Dopamine D1-like receptors and reward-related incentive learning 

  3. J. Neurosci. Boyson 6 3177 1986 10.1523/JNEUROSCI.06-11-03177.1986 Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain 

  4. Anal. Biochem. Bradford 72 248 1976 10.1016/0003-2697(76)90527-3 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding 

  5. J. Pharmacol. Exp. Ther. Clausing 274 614 1995 Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects 

  6. C.A. Crawford, A.R. Zavala, P.E. Karper, R.L. Collins, T.L. Meier, J.B. Watson, S.A. McDougall, Amphetamine treatment during the preweanling period produces long-term changes in striatal protein kinase A activity, Pharmacol., Biochem. Behav. (in press). 

  7. Neurotoxicol. Teratol. Dow-Edwards 20 133 1998 10.1016/S0892-0362(97)00095-0 Preweaning cocaine administration alters the adult response to quipazine: Comparison with fluoxetine 

  8. Pharmacol., Biochem. Behav. Fields 40 881 1991 10.1016/0091-3057(91)90101-7 Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity 

  9. Dev. Brain Res. Frick 88 158 1995 10.1016/0165-3806(95)00094-T The effects of cocaine on cerebral metabolic function in periweanling rats: The roles of serotonergic and dopaminergic uptake blockade 

  10. Gibb 269 1994 Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse Neurochemical mechanisms of toxicity 

  11. NIDA Res. Monogr. Gibb 173 128 1997 Neurotoxicity of amphetamine and their metabolites 

  12. Life Sci. Huang 61 2219 1997 10.1016/S0024-3205(97)00924-7 Amphetamine induces hydroxyl radical formation in the striatum of rats 

  13. J. Am. Acad. Child Adolesc. Psychiatry Jacobvitz 29 677 1990 10.1097/00004583-199009000-00001 Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review 

  14. Eur. J. Pharmacol. Johansson 269 149 1994 10.1016/0922-4106(94)90081-7 Forskolin-induced up-regulation and functional supersensitivity of dopamine D2 long receptors expressed by Ltk− cells 

  15. Exp. Neurol. Joyce 113 261 1991 10.1016/0014-4886(91)90016-6 Differential responses of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine: I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine systems 

  16. Nature Kebabian 277 93 1979 10.1038/277093a0 Multiple receptors for dopamine 

  17. Kirk 237 1982 Experimental Design 

  18. Brain Res. Kleven 532 265 1990 10.1016/0006-8993(90)91768-C Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain 

  19. Kuczenski 81 1994 Amphetamine and its Analogs: Pharmacology, Toxicology, and Abuse Neurochemistry of amphetamine 

  20. J. Neurochem. 68 2032 1997 10.1046/j.1471-4159.1997.68052032.x Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine 

  21. Brain Res. Marshall 493 247 1989 10.1016/0006-8993(89)91160-8 Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: An autoradiographic analysis 

  22. Exp. Clin. Psychopharmacol. McDougall 7 208 1999 10.1037/1064-1297.7.3.208 Effects of repeated methylphenidate treatment in the young rat: Sensitization of both locomotor activity and stereotyped sniffing 

  23. Cell. Mol. Life Sci. Micheau 55 534 1999 10.1007/s000180050312 Protein kinases: Which one is the memory molecule? 

  24. Science Nestler 278 58 1997 10.1126/science.278.5335.58 Molecular and cellular basis of addiction 

  25. Brain Res. Ricaurte 303 359 1984 10.1016/0006-8993(84)91221-6 Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve terminals 

  26. Neurochem. Int. Richtand 31 131 1997 10.1016/S0197-0186(96)00097-6 Quantification of dopamine D1 and D2 receptor mRNA levels associated with the development of behavioral sensitization in amphetamine treated rats 

  27. Brain Res. Robertson 267 179 1983 10.1016/0006-8993(83)91055-7 Chronic D-amphetamine and phencyclidine: Effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems 

  28. Brain Res. Rev. Robinson 11 157 1986 10.1016/0165-0173(86)90002-0 Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis 

  29. J. Pharmacol. Exp. Ther. Roseboom 255 197 1990 Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum 

  30. J. Neurochem. Schettini 59 1667 1992 10.1111/j.1471-4159.1992.tb10997.x Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: Involvement of G proteins in the development of receptor supersensitivity 

  31. Eur. J. Pharmacol. Shi 370 241 1999 10.1016/S0014-2999(99)00110-7 Chronic haloperidol alters dopamine receptors: Effects of cocaine exposure during the preweanling period 

  32. Trends Pharmacol. Sci. Sibley 68 97 1992 Molecular biology of dopamine receptors 

  33. J. Am. Acad. Child Adolesc. Psychiatry Spencer 35 409 1996 10.1097/00004583-199604000-00008 Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle 

  34. Neurotoxicol. Teratol. Vorhees 22 255 2000 10.1016/S0892-0362(99)00071-9 Evaluation of neonatal exposure to cocaine on learning, activity, startle, scent marking, immobility, and plasma cocaine concentrations 

  35. Neurology Wagner 30 547 1980 10.1212/WNL.30.5.547 Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate 

  36. Pharmacol. Rev. Walaas 43 299 1991 Protein phosphorylation and neuronal function 

  37. Cell. Mol. Neurobiol. Wanderoy 17 547 1997 10.1023/A:1026367023458 Molecular mechanisms underlying forskolin-mediated up-regulation of human dopamine D2L receptors 

  38. NeuroReport Wanderoy 8 2971 1997 10.1097/00001756-199709080-00033 Dopamine D2 receptor upregulation in rat neostriatum following in vivo infusion of forskolin 

  39. Psychiatr. Clin. North Am. Wilens 15 191 1992 10.1016/S0193-953X(18)30265-X The stimulants 

  40. Pediatrics Wolraich 86 95 1990 10.1542/peds.86.1.95 Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로